$PFE Recent News Shire plunges, Balfour Beatty gains:

New Post Public Reply Private Reply Replies (0) Message Board

Oct 20, 2014 at 12:02 PM

$PFE Recent News

Shire plunges, Balfour Beatty gains: European stock movers 5:01 a.m. Oct. 15, 2014 - Carla Mozee
Pfizer breast cancer treatment granted FDA priority review status 8:55 a.m. Oct. 13, 2014 - Chelsey Dulaney
The automaker the top performers like the most 12:15 p.m. Oct. 1, 2014 - Mark Hulbert
Do the top performers like any bond funds more than Bill Gross’ new fund? 11:30 a.m. Oct. 1, 2014 - Mark Hulbert
Copycat technology is the next big thing 8:51 a.m. Sept. 29, 2014 - Marek Fuchs
Actavis reportedly in talks to buy Salix Pharma 11:51 a.m. Sept. 24, 2014 - Russ Britt
Pfizer held takeover talks with Actavis 1:32 a.m. Sept. 24, 2014 - Jonathan D. Rockoff
CF Industries rises on merger talks; AstraZeneca, AbbVie fall 3:21 p.m. Sept. 23, 2014 - Sue Chang
Actavis shares rise on report of Pfizer approach 2:49 p.m. Sept. 23, 2014 - Ciara Linnane
Burger King, AbbVie among stocks hit by new tax inversion rules 2:40 p.m. Sept. 23, 2014 - Ben Eisen
Shire, AstraZeneca fall in London after U.S. tax move 12:19 p.m. Sept. 23, 2014 - Carla Mozee
The headwinds that Facebook faces 12:52 p.m. Sept. 11, 2014 - Mark Hulbert
Stock buybacks blamed for lack of U.S. prosperity 4:51 p.m. Sept. 2, 2014 - Russ Britt
Here’s what history says about the stock market in September 5:39 a.m. Sept. 2, 2014 - Mark Hulbert
Inversions are not such a sweet deal for fund investors 1:47 p.m. Aug. 18, 2014 - Chuck Jaffe
Tax inversions can be bad for shareholders — and for America 2:31 p.m. Aug. 17, 2014 - Chuck Jaffe
Investors sent on a wild ride by hostile deals 12:56 p.m. Aug. 15, 2014 - David Weidner
Timing this market is guaranteed to make you a loser 1:02 p.m. Aug. 8, 2014 - Mark Hulbert
Tax inversions help, not hurt, the economy 7:20 a.m. Aug. 8, 2014 - Diana Furchtgott-Roth
Mega caps with mega recommendations 7:54 a.m. Aug. 6, 2014 - Mark Hulbert

Guru Stocks at 52-Week Lows: GOOG, PFE, UN, E, MTU 59 min ago - GuruFocus.com
Dow Jones (DJIA) Today: Pfizer (PFE) Lower 11:00 a.m. Today - TheStreet.com
LabCorp launches new HIV test 10:40 a.m. Today - Seeking Alpha
5 Best Biotech Stocks to Buy Now 6:02 a.m. Today - InvestorPlace.com
FDA clears Pfizer's abuse deterrent pain med 5:20 p.m. Oct. 17, 2014 - Seeking Alpha
UPDATE: FDA Has Approved New Labeling on Pfizer's Embeda 3:27 p.m. Oct. 17, 2014 - benzinga.com
Belviq Sales Dip: What To Watch For Ahead 1:13 p.m. Oct. 17, 2014 - Seeking Alpha
Panel Votes to Keep Strong Warning on Smoking-Cessation Drug 5:58 p.m. Oct. 16, 2014 - The Wall Street Journal Interactive Edition
Ad Comm votes to retain Chantix label 3:56 p.m. Oct. 16, 2014 - Seeking Alpha
The 4 Stocks That Held the DJIA Down 3:25 p.m. Oct. 16, 2014 - 247WallSt.com
Baxter Q3 Beats As Hemophilia Drugs Fend Off Rivals 2:07 p.m. Oct. 16, 2014 - Investors Business Daily
3 Stocks Dragging In The Drugs Industry 1:22 p.m. Oct. 16, 2014 - TheStreet.com
Ad Comm meeting approaches for Novartis' psoriasis therapy candidate 11:46 a.m. Oct. 16, 2014 - Seeking Alpha
Shire Can Thrive Without AbbVie, Say Analysts 10:19 a.m. Oct. 16, 2014 - Investors Business Daily
Baxter’s Medical-Products Sales Rise 7:35 a.m. Oct. 16, 2014 - The Wall Street Journal Interactive Edition
AbbVie Flip-Flop Hands U.S. Government Tax-Deal Victory 12:36 a.m. Oct. 16, 2014 - The Wall Street Journal Interactive Edition
Dogs Of The Dow: 2014 Third Quarter Review 4:14 p.m. Oct. 15, 2014 - Seeking Alpha
Multiple Contraction Can Hit Pfizer 3:46 p.m. Oct. 15, 2014 - Seeking Alpha
Shire Falls, AbbVie Questioned On Buyout Backtrack 12:11 p.m. Oct. 15, 2014 - Investors Business Daily
Today's Market: Inversions, Tech Deals And Upgrades/Downgrades Moving These Names 11:32 a.m. Oct. 15, 2014 - Seeking Alpha

ViiV Healthcare Expands Program to Reduce HIV Disparities in Southern U.S. 9:00 a.m. Today - PR Newswire - PRF
Acquisition Updates, Drug Approval, Drug Development Discontinuation, and Contract Update - Research Reports on AbbVie, Gilead, Pfizer, Lilly and Aetna 8:35 a.m. Today - PR Newswire - PRF
Pfizer Announces FDA Acceptance Of Palbociclib New Drug Application With Priority Review 11:59 a.m. Oct. 13, 2014 - BusinessWire - BZX
Marketing Application Update, Acquisitions, Collaborations, FDA Approvals, and Structural Changes - Research Reports on Gilead, BD, Pfizer, AbbVie and Novartis 8:55 a.m. Oct. 10, 2014 - PR Newswire - PRF
Pfizer to Present New Data Evaluating Safety, Tolerability and Immunogenicity of its Investigational Staphylococcus aureus Vaccine Candidate at IDWeek 2014™ 8:00 a.m. Oct. 10, 2014 - BusinessWire - BZX
Top 10 Health Care Trends Report Finds Opportunities to Achieve "Triple Aim" 2:45 p.m. Oct. 9, 2014 - PR Newswire - PRF
Kane Biotech Appoints Mark Nawacki to the Board of Directors 8:06 a.m. Oct. 8, 2014 - Marketwired
Pfizer To Present Safety And Immunogenicity Data From A Phase 2 Study Of Its Investigational Meningococcal Group B Vaccine, Bivalent rLP2086, Co-Administered With A Licensed Human Papillomavirus Vaccine 8:01 a.m. Oct. 8, 2014 - BusinessWire - BZX
Portola Pharmaceuticals Announces Phase 3 ANNEXA(TM)-A Study of Andexanet Alfa and Eliquis (Apixaban) Met Primary and Secondary Endpoints With High Statistical Significance 8:00 a.m. Oct. 1, 2014 - GlobeNewswire
Positive Study Results, Acquisitions, Drug Approval, Regulatory Updates, and Collaborations - Research Reports on Gilead, Pfizer, AbbVie, Pacira and Thermo Fisher 8:50 a.m. Sept. 30, 2014 - PR Newswire - PRF
Pfizer And Kyowa Hakko Kirin To Collaborate On Immuno-Oncology Combination Study 8:00 p.m. Sept. 29, 2014 - BusinessWire - BZX
Fitch Affirms Pfizer's IDR at 'A+'; Outlook Stable 3:30 p.m. Sept. 26, 2014 - BusinessWire - BZX
GlycoMimetics Announces a Delay in the Initiation of the Phase 3 Trial With Rivipansel 9:01 a.m. Sept. 26, 2014 - GlobeNewswire
Pain Therapeutics Expands Pipeline With FENROCK(TM), an Abuse-Deterrent Pain Patch 7:29 a.m. Sept. 26, 2014 - GlobeNewswire
Pfizer Completes Acquisition Of InnoPharma 8:00 a.m. Sept. 25, 2014 - BusinessWire - BZX
Active Equities to Watch in Pharma Industry - Pfizer, BioDelivery Sciences Intl., Repros Therapeutics, Catalent, and Nektar Therapeutics 8:30 a.m. Sept. 24, 2014 - PR Newswire - PRF
Pfizer Invites Public to View and Listen to Webcast of October 28 Conference Call with Analysts 10:39 a.m. Sept. 23, 2014 - BusinessWire - BZX
Kim Cattrall Encourages Women to Embrace Menopause with Style 8:00 a.m. Sept. 23, 2014 - BusinessWire - BZX
Licensing Agreements, Results of Clinical Trials, and Acquisitions - Research Reports on Gilead, AbbVie, Pfizer, Auxilium and Endo 9:05 a.m. Sept. 22, 2014 - PR Newswire - PRF
Bristol-Myers Squibb and Pfizer Announce Charitable Donations of More Than $1 Million to Support Cardiovascular Education for Patients and Caregivers 8:01 a.m. Sept. 22, 2014 - BusinessWire - BZX

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AEC Firms Revamp Strategies Amid Talent Tug-of-War

The State of Compensation in AEC Sit back and chew on this—AEC firms are playing a whole new ball game when it comes to compensating their talent. FMI Corporation’s 2026 Compensation Trends Study is putting a spotlight on what really goes on behind the scenes in architecture, engineering, and construction firms. This is about more than just tossing some coin for a...

Scientel Solutions Connects North Central Athletes on Road

Boosting Connectivity for Student-Athletes Here's a nugget that slips under the radar unless you're looking with both eyes open: Scientel Solutions, from Aurora, Illinois, is shaking up the connectivity game for North Central College's athletic department. These folks have realized something many don't quite grasp—keeping student-athletes connected is no luxury; it's...

Huawei Unleashes Bold New Flagship Devices in Munich

Huawei's Bold Move in Munich When I hear about yet another product launch, I often roll my eyes but this one, folks, deserves a second glance. Huawei dropped a news bomb in Munich with their 'Chase the Wild' event, unveiling a huge lineup of flagship gadgets. This isn't your run-of-the-mill release; the mix of smart wearables, tablets, smartphones, and audio gear marks...

Codoxo Snags 2026 Award for AI Payment Innovation

Revolutionizing Healthcare Payment with AI Ah, healthcare and payments—two things that can make even the most patient folks lose their cool. But here comes Codoxo, shaking up this landscape with its Point Zero Payment Integrity solution, and someone's finally giving them the nod they deserve. For those of us who have been in the game for a while, this announcement is...

Supercharged Entertainment's Big Bet in Ohio's Polaris

Fasten your seatbelts, folks—because there's a tinge of burnt rubber in the air at Columbus's Polaris Center. Supercharged Entertainment, the big guns in indoor karting, just kicked off construction at their brand-new venue, and it’s looking like a gearhead's paradise. A sprawling 16-acre parcel is set to become a haven for adrenaline junkies come Summer 2027. A Bold...

DeFi Technologies Gains More Time for Nasdaq Compliance

DeFi Must Step Up To Meet Compliance Challenge Alright, folks, here's the scoop: DeFi Technologies just picked up another 180 days from Nasdaq to get its act together and hit that crucial one-buck minimum bid price. It's like getting extra time on a pop quiz you forgot to study for—useful, but no guarantee they'll pass. What Led to the Extra Time? These guys over at...

Narwal Unveils 2026 AI Cleaning Lineup at IFA Berlin

A Fresh Sweep with AI: Narwal's 2026 Lineup Hot off the press from Berlin's IFA 2026, Narwal is making some serious waves with its latest household cleaning gadgets. This isn't just another batch of robot helpers; Narwal's aiming to redefine what AI-driven cleaning can do for your home. FlowWash: Not Just Another Cleaning Gimmick Narwal's been at this game for over a...

Capricor Faces Lawsuit: Investors Should Take Note

Capricor Therapeutics: A Rough Road Ahead If you've got skin in the game with Capricor Therapeutics, these latest developments might have you feeling a bit queasy. Forget the greasy diner fare today; this situation calls for some serious contemplation and maybe a bit of antacid. Over at NASDAQ:CAPR, the air is hot with allegations, stock price nosedives, and looming legal...

Ohio's Visionary Leadership Honored with Prestigious Award

Award for Exceptional Vision Care Leadership Ain't every day you see a politician scooping up awards for making a real difference in folks' lives. Yet here we are, tipping our hats to Ohio's Governor Mike DeWine, who's just been dubbed the honcho with the golden eye for children's vision care in the 12th annual Bonnie Strickland Champion for Children's Vision Award. Hats...

Mitrade EU Enhances Investor Safety with New Insurance

Mitrade's New Insurance: A Safety Net? Mitrade EU is amping up its game with some fresh insurance perks that catch the eye. They're slapping on some extra insolvency protection for clients trading under their CySEC license. Now that sounds like a financial shield anyone would want. Basically, they're adding another layer to the basic regulatory protections, and without...